Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene - PubMed (original) (raw)
. 2003 May 1;101(9):3416-23.
doi: 10.1182/blood-2002-02-0578. Epub 2003 Jan 2.
Affiliations
- PMID: 12511423
- DOI: 10.1182/blood-2002-02-0578
Free article
Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene
Gilles Marodon et al. Blood. 2003.
Free article
Abstract
Achieving cell-specific expression of a therapeutic transgene by gene transfer vectors represents a major goal for gene therapy. To achieve specific expression of a transgene in CD4(+) cells, we have generated lentiviral vectors expressing the enhanced green fluorescent protein (eGFP) reporter gene under the control of regulatory sequences derived from the CD4 gene--a minimal promoter and the proximal enhancer, with or without the silencer. Both lentiviral vectors could be produced at high titers (more than 10(7) infectious particles per milliliter) and were used to transduce healthy murine hematopoietic stem cells (HSCs). On reconstitution of RAG-2-deficient mice with transduced HSCs, the specific vectors were efficiently expressed in T cells, minimally expressed in B cells, and not expressed in immature cells of the bone marrow. Addition of the CD4 gene-silencing element in the vector regulatory sequences led to further restriction of eGFP expression into CD4(+) T cells in reconstituted mice and in ex vivo-transduced human T cells. Non-T CD4(+) dendritic and macrophage cells derived from human CD34(+) cells in vitro expressed the transgene of the specific vectors, albeit at lower levels than CD4(+) T cells. Altogether, we have generated lentiviral vectors that allow specific targeting of transgene expression to CD4(+) cells after differentiation of transduced mice HSCs and human mature T cells. Ultimately, these vectors may prove useful for in situ injections for in vivo gene therapy of HIV infection or genetic immunodeficiencies.
Similar articles
- Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
Cui Y, Golob J, Kelleher E, Ye Z, Pardoll D, Cheng L. Cui Y, et al. Blood. 2002 Jan 15;99(2):399-408. doi: 10.1182/blood.v99.2.399. Blood. 2002. PMID: 11781219 - Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.
Lotti F, Menguzzato E, Rossi C, Naldini L, Ailles L, Mavilio F, Ferrari G. Lotti F, et al. J Virol. 2002 Apr;76(8):3996-4007. doi: 10.1128/jvi.76.8.3996-4007.2002. J Virol. 2002. PMID: 11907239 Free PMC article. - In situ transduction of stromal cells and thymocytes upon intrathymic injection of lentiviral vectors.
Marodon G, Klatzmann D. Marodon G, et al. BMC Immunol. 2004 Aug 19;5:18. doi: 10.1186/1471-2172-5-18. BMC Immunol. 2004. PMID: 15318949 Free PMC article. - Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases.
Poletti V, Mavilio F. Poletti V, et al. Viruses. 2021 Aug 2;13(8):1526. doi: 10.3390/v13081526. Viruses. 2021. PMID: 34452394 Free PMC article. Review. - Clinical use of lentiviral vectors.
Milone MC, O'Doherty U. Milone MC, et al. Leukemia. 2018 Jul;32(7):1529-1541. doi: 10.1038/s41375-018-0106-0. Epub 2018 Mar 22. Leukemia. 2018. PMID: 29654266 Free PMC article. Review.
Cited by
- Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.
Tezgel AÖ, Gonzalez-Perez G, Telfer JC, Osborne BA, Minter LM, Tew GN. Tezgel AÖ, et al. Mol Ther. 2013 Jan;21(1):201-9. doi: 10.1038/mt.2012.209. Epub 2012 Oct 16. Mol Ther. 2013. PMID: 23070119 Free PMC article. - Viral vector platforms within the gene therapy landscape.
Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Bulcha JT, et al. Signal Transduct Target Ther. 2021 Feb 8;6(1):53. doi: 10.1038/s41392-021-00487-6. Signal Transduct Target Ther. 2021. PMID: 33558455 Free PMC article. Review. - Transgene expression in various organs post BM-HSC transplantation.
Wang N, Rajasekaran N, Hou T, Mellins ED. Wang N, et al. Stem Cell Res. 2014 Jan;12(1):209-21. doi: 10.1016/j.scr.2013.10.010. Epub 2013 Nov 2. Stem Cell Res. 2014. PMID: 24270160 Free PMC article. - Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells.
deRonde BM, Torres JA, Minter LM, Tew GN. deRonde BM, et al. Biomacromolecules. 2015 Oct 12;16(10):3172-9. doi: 10.1021/acs.biomac.5b00795. Epub 2015 Sep 14. Biomacromolecules. 2015. PMID: 26324222 Free PMC article. - In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy.
Zhang W, Huang X. Zhang W, et al. J Hematol Oncol. 2024 Nov 13;17(1):110. doi: 10.1186/s13045-024-01633-7. J Hematol Oncol. 2024. PMID: 39533415 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials